Free Trial

Mercer Global Advisors Inc. ADV Reduces Position in The Cooper Companies, Inc. (NASDAQ:COO)

Cooper Companies logo with Medical background

Mercer Global Advisors Inc. ADV trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 27.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,363 shares of the medical device company's stock after selling 3,244 shares during the quarter. Mercer Global Advisors Inc. ADV's holdings in Cooper Companies were worth $769,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Byrne Asset Management LLC purchased a new position in Cooper Companies during the fourth quarter worth approximately $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies in the 4th quarter worth $34,000. New Age Alpha Advisors LLC purchased a new position in shares of Cooper Companies during the 4th quarter worth $38,000. Covestor Ltd boosted its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the last quarter. Finally, West Financial Advisors LLC purchased a new stake in shares of Cooper Companies in the fourth quarter valued at about $49,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Robert W. Baird decreased their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup lowered their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, Piper Sandler restated an "overweight" rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Get Our Latest Stock Report on COO

Cooper Companies Trading Down 0.8 %

Shares of COO stock opened at $82.27 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $69.81 and a fifty-two week high of $112.38. The company has a 50 day moving average price of $80.54 and a 200 day moving average price of $90.93. The stock has a market capitalization of $16.45 billion, a P/E ratio of 42.19, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts' consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Recommended Stories

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines